121 related articles for article (PubMed ID: 22842952)
1. Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria.
Bruyère O; Fossi M; Zegels B; Leonori L; Hiligsmann M; Neuprez A; Reginster JY
Rheumatol Int; 2013 Apr; 33(4):973-8. PubMed ID: 22842952
[TBL] [Abstract][Full Text] [Related]
2. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
3. A FRAX® model for the assessment of fracture probability in Belgium.
Johansson H; Kanis JA; McCloskey EV; Odén A; Devogelaer JP; Kaufman JM; Neuprez A; Hiligsmann M; Bruyere O; Reginster JY
Osteoporos Int; 2011 Feb; 22(2):453-61. PubMed ID: 20352409
[TBL] [Abstract][Full Text] [Related]
4. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
Adler RA; Hastings FW; Petkov VI
Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.
Koo JS; Moon SH; Lee H; Park S; Yu YM; Kang HY
PLoS One; 2020; 15(12):e0244759. PubMed ID: 33382798
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.
Marques A; Lourenço Ó; Ortsäter G; Borgström F; Kanis JA; da Silva JA
Calcif Tissue Int; 2016 Aug; 99(2):131-41. PubMed ID: 27016370
[TBL] [Abstract][Full Text] [Related]
8. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
[TBL] [Abstract][Full Text] [Related]
9. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.
Hiligsmann M; Ben Sedrine W; Bruyère O; Reginster JY
Osteoporos Int; 2013 Aug; 24(8):2291-300. PubMed ID: 23371359
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of using non-hip bone density inputs with FRAX®.
Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
Osteoporos Int; 2012 Mar; 23(3):853-60. PubMed ID: 22008881
[TBL] [Abstract][Full Text] [Related]
12. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
[TBL] [Abstract][Full Text] [Related]
13. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX.
Kälvesten J; Lui LY; Brismar T; Cummings S
Bone; 2016 May; 86():30-5. PubMed ID: 26921822
[TBL] [Abstract][Full Text] [Related]
14. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
[TBL] [Abstract][Full Text] [Related]
15. FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.
Greenspan SL; Perera S; Nace D; Zukowski KS; Ferchak MA; Lee CJ; Nayak S; Resnick NM
J Am Geriatr Soc; 2012 Apr; 60(4):684-90. PubMed ID: 22316237
[TBL] [Abstract][Full Text] [Related]
16. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
Leslie WD; Morin SN; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
[TBL] [Abstract][Full Text] [Related]
17. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
[TBL] [Abstract][Full Text] [Related]
18. Establishing and evaluating FRAX
Chan DC; McCloskey EV; Chang CB; Lin KP; Lim LC; Tsai KS; Yang RS
J Formos Med Assoc; 2017 Mar; 116(3):161-168. PubMed ID: 27117886
[TBL] [Abstract][Full Text] [Related]
19. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
20. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
